Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.
The association between tricyclic antidepressant (TCA) use in children and increased risk of sudden death is unclear, but still possible. There are suitable alternatives to TCAs for all of the indications in which they have shown efficacy. A prudent practice model for the utilisation of TCAs has been developed. This includes initial utilisation of alternative agents, with TCAs as secondary or tertiary choices; informed consent from patient and family, including mention of the possible relationship of TCA with sudden death; vigilance of the emerging literature; and finally, systematic monitoring of patients, including electrocardiograms, drug serum concentrations and vital signs. This protocol needs to be validated with regard to utility and the degree of assistance it provides in the management of children treated with TCAs.
Varley
C K
CK
Division of Psychiatry and Behavioral Sciences, University of Washington, Seattle, USA. cvarley@u.washington.edu
D000293:Adolescent; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects* / Q000097:blood; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy*; D003645:Death, Sudden / Q000453:epidemiology / Q000209:etiology*; D003891:Desipramine / Q000009:adverse effects* / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012307:Risk Factors
D000929:Antidepressive Agents, Tricyclic; D003891:Desipramine